BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8855145)

  • 1. Standardization of pyridinium crosslinks, pyridinoline and deoxypyridinoline, for use as biochemical markers of collagen degradation.
    Robins SP; Duncan A; Wilson N; Evans BJ
    Clin Chem; 1996 Oct; 42(10):1621-6. PubMed ID: 8855145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standardization of marker assays--pyridinoline/deoxypyridinoline.
    Kent GN
    Scand J Clin Lab Invest Suppl; 1997; 227():73-9. PubMed ID: 9127470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Method for the isolation and purification of pyridinoline and deoxypyridinoline crosslinks from bone by liquid chromatographic techniques.
    Meddah B; Kamel S; Giroud C; Brazier M
    Prep Biochem Biotechnol; 1999 Feb; 29(1):63-75. PubMed ID: 10069434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyridinium crosslinks as markers of bone resorption in patients with breast cancer.
    Paterson CR; Robins SP; Horobin JM; Preece PE; Cuschieri A
    Br J Cancer; 1991 Nov; 64(5):884-6. PubMed ID: 1931610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of collagen crosslinks; potential biomarkers for bone disorders.
    McGuinness BJ; Casserly UM; Power MJ; Fottrell PF
    Biochem Soc Trans; 1995 May; 23(2):386S. PubMed ID: 7672419
    [No Abstract]   [Full Text] [Related]  

  • 6. Urinary glycosylated, free and total pyridinoline and free and total deoxypyridinoline in diabetes mellitus.
    Cloos C; Wahl P; Hasslacher C; Traber L; Kistner M; Jurkuhn K; Schmidt-Gayk H
    Clin Endocrinol (Oxf); 1998 Mar; 48(3):317-23. PubMed ID: 9578822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary excretion of pyridinium crosslinks of collagen in patients with osteoporosis and the effects of bone fracture.
    McLaren AM; Hordon LD; Bird HA; Robins SP
    Ann Rheum Dis; 1992 May; 51(5):648-51. PubMed ID: 1616331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid analysis of pyridinoline and deoxypyridinoline in biological samples by liquid chromatography with mass spectrometry and a silica hydride column.
    Naffa R; Watanabe S; Zhang W; Maidment C; Singh P; Chamber P; Matyska MT; Pesek JJ
    J Sep Sci; 2019 Apr; 42(8):1482-1488. PubMed ID: 30680922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary excretion of pyridinium crosslinks in healthy 4-10 year olds.
    Husain SM; Mughal Z; Williams G; Ward K; Smith CS; Dutton J; Fraser WD
    Arch Dis Child; 1999 Apr; 80(4):370-3. PubMed ID: 10086947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting the assay of urinary 3-hydroxy pyridinium crosslinks of collagen as markers of bone resorption.
    Colwell A; Russell RG; Eastell R
    Eur J Clin Invest; 1993 Jun; 23(6):341-9. PubMed ID: 8344334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxypyridinium collagen crosslinks in serum, urine, synovial fluid and synovial tissue in patients with rheumatoid arthritis compared with osteoarthritis.
    Kaufmann J; Mueller A; Voigt A; Carl HD; Gursche A; Zacher J; Stein G; Hein G
    Rheumatology (Oxford); 2003 Feb; 42(2):314-20. PubMed ID: 12595629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of urinary pyridinium crosslink excretion as a marker of bone resorption in the rat.
    Egger CD; Mühlbauer RC; Felix R; Delmas PD; Marks SC; Fleisch H
    J Bone Miner Res; 1994 Aug; 9(8):1211-9. PubMed ID: 7976504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Assay of cross-linking molecules of collagen (pyridinolines) in the study of the degradation of bone tissue and articular cartilage].
    Uebelhart D; Delmas PD
    Pathol Biol (Paris); 1993 Dec; 41(10):951-61. PubMed ID: 8159476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous free and glycosylated pyridinium crosslink determination in urine: validation of an HPLC-fluorescence method using a deoxypyridinoline homologue as internal standard.
    Monticelli E; Aman CS; Costa ML; Rota P; Bogdan D; Allevi P; Cighetti G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Sep; 879(26):2764-71. PubMed ID: 21855424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-linking of collagen. Isolation, structural characterization and glycosylation of pyridinoline.
    Robins SP
    Biochem J; 1983 Oct; 215(1):167-73. PubMed ID: 6626172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence of increased bone resorption in neurofibromatosis type 1 using urinary pyridinium crosslink analysis.
    Stevenson DA; Schwarz EL; Viskochil DH; Moyer-Mileur LJ; Murray M; Firth SD; D'Astous JL; Carey JC; Pasquali M
    Pediatr Res; 2008 Jun; 63(6):697-701. PubMed ID: 18317233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The urinary excretion of the collagen degradation markers pyridinoline and deoxypyridinoline in an experimental rat model of alcoholic bone disease.
    Preedy VR; Sherwood RA; Akpoguma CI; Black D
    Alcohol Alcohol; 1991; 26(2):191-8. PubMed ID: 1878079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary hydroxypyridinium crosslinks of collagen in population-based screening for overt vertebral osteoporosis: results of a pilot study.
    Seibel MJ; Woitge H; Scheidt-Nave C; Leidig-Bruckner G; Duncan A; Nicol P; Ziegler R; Robins SP
    J Bone Miner Res; 1994 Sep; 9(9):1433-40. PubMed ID: 7817828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis.
    Delmas PD; Schlemmer A; Gineyts E; Riis B; Christiansen C
    J Bone Miner Res; 1991 Jun; 6(6):639-44. PubMed ID: 1887826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption.
    Robins SP; Woitge H; Hesley R; Ju J; Seyedin S; Seibel MJ
    J Bone Miner Res; 1994 Oct; 9(10):1643-9. PubMed ID: 7817812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.